A series of novel isoxazolyl-1,4-benzodiazepine-5-ones 4 have been synthesized by the reaction of phenacyl isoxazolylamines 1 with o-nitrobenzoic acids 2 to furnish different (E)-N-(3-methyl-5-styrylisoxazol-4-yl)-2-nitro-N-(2-oxo-2-phenylethyl)benzamides 3, which on treatment with Fe-AcOH underwent reductive cyclization to afford the target compounds 4a-w. The newly synthesized compounds were characterized by IR, (HNMR)-H-1, (CNMR)-C-13, and HRMS analysis. The target compounds 4a-w were evaluated for their invitro antimicrobial activity. Among the synthesized compounds, compounds 4r, 4s, 4t, 4u, 4v and 4w showed potent antimicrobial activity as compared with the reference drugs. Most of the newly synthesized title compounds have shown good to excellent antimicrobial activity.
机构:
Hebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R ChinaHebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R China
Yin, Liuyan
Wang, Lanzhi
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R ChinaHebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R China
Wang, Lanzhi
Li, Xiaoqing
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R ChinaHebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R China
Li, Xiaoqing
An, Yingshuang
论文数: 0引用数: 0
h-index: 0
机构:
Hebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R ChinaHebei Normal Univ, Coll Chem & Mat Sci, Shijiazhuang 050024, Peoples R China
机构:
AstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, EnglandAstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, England
Sherborne, Grant J.
Diene, Coura
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, EnglandAstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, England
Diene, Coura
Kemmitt, Paul
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, EnglandAstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, England
Kemmitt, Paul
Smith, Andrew D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ St Andrews, Eastchem, Sch Chem, St Andrews KY16 9ST, Fife, ScotlandAstraZeneca, Med Chem Oncol R&D Res & Early Dev, Discovery Ctr, Cambridge CB2 0AA, England
机构:
Center for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, MoscowCenter for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, Moscow
Krichevskii É.S.
Alekseeva L.M.
论文数: 0引用数: 0
h-index: 0
机构:
Center for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, MoscowCenter for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, Moscow
Alekseeva L.M.
Anisimova O.S.
论文数: 0引用数: 0
h-index: 0
机构:
Center for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, MoscowCenter for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, Moscow
Anisimova O.S.
Parshin V.A.
论文数: 0引用数: 0
h-index: 0
机构:
Center for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, MoscowCenter for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, Moscow
Parshin V.A.
Asnina V.V.
论文数: 0引用数: 0
h-index: 0
机构:
Center for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, MoscowCenter for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, Moscow
Asnina V.V.
Granik V.G.
论文数: 0引用数: 0
h-index: 0
机构:
Center for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, MoscowCenter for Drug Chemistry, All-Russia Research Institute of Pharmaceutical Chemistry, Moscow